Derniers essais


EudraCT Number: 2006-004203-19 Sponsor Protocol Number: ALS-3-06-A-401 Start Date: 2006-11-24
Sponsor Name: AIR LIQUIDE Santé INTERNATIONAL
Full Title: Etude de l'efficacité du Kalinox 170 bar lors de la réalisation de biopsies de lésions focales hépatiques
Medical condition: Analgésie - biopsie hépatique percutanée sous échographie pour diagnostic de lésions focales
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2005-004754-27 Sponsor Protocol Number: HOE-901/6060 Start Date: 2006-11-24
Sponsor Name: Cardiff University
Full Title: Comparison of insulin detemir and insulin glargine in patients with Type 2 diabetes
Medical condition: Type 2 Diabetes
Disease: Version SOC Term Classification Code Term Level
8.1 10045242 Type II diabetes mellitus LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2007-003906-89 Sponsor Protocol Number: 2163/2006 Start Date: 2006-11-23
Sponsor Name: Istituto Fisiologia Clinica, CNR
Full Title: Insulin Therapy in non-diabetic patients with Acute Coronary Syndromes: Effect of strict glycemic control on systemic endothelial function, coronary flow reserve, and left ventricular contractility
Medical condition: Iperglycemia with Acute Coronary Syndrome
Disease: Version SOC Term Classification Code Term Level
9.1 10051592 Acute coronary syndrome LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Prematurely Ended)
Trial results: (No results available)

EudraCT Number: 2005-004234-41 Sponsor Protocol Number: 4102000 Start Date: 2006-11-23
Sponsor Name: Otto-von-Guericke Universität Magdeburg
Full Title: Dosisdichte 1st-line Therapie des metastasierten Mammakarzinoms mit Paclitaxel und liposomalem Doxorubicin (Myocet®)
Medical condition: metastasiertes Mammakarzinom
Disease: Version SOC Term Classification Code Term Level
9.1 10006187 Breast cancer LLT
Population Age: Adults, Elderly Gender: Female
Trial protocol: DE (Prematurely Ended)
Trial results: View results
EudraCT Number: 2006-003385-34 Sponsor Protocol Number: CRU.LUMC.001 Start Date: 2006-11-23
Sponsor Name: Boehringer Ingelheim Pharma GmbH & Co. KG
Full Title: The effect of tiotropium-bromide on deep inspiration-induced bronchodilation and airway responsiveness in asthma.
Medical condition: 24 patients with mild persistent asthma will participate in the study. All patients will be allergic to one or more airborne allergens, hyperresponsive to histamine (PC20
Disease: Version SOC Term Classification Code Term Level
8.1 10003638 Atopic asthma LLT
Population Age: Adults Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2006-002676-18 Sponsor Protocol Number: 26-01 Start Date: 2006-11-23
Sponsor Name: WELEDA AG DEUTSCHLAND
Full Title: Randomized, open-label phase 2 study on post-relapse disease-free survival (PRDFS) with the Viscum-album Extract (VA-E) Iscador P or oral Etoposide in spindle-cell bone-sarcoma patients in complete...
Medical condition: spindle-cell bone-sarcoma patients in complete remission after surgery for second relapse.
Disease: Version SOC Term Classification Code Term Level
9.1 10049067 Spindle cell sarcoma LLT
Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2006-002950-32 Sponsor Protocol Number: 1502 Start Date: 2006-11-23
Sponsor Name: Gentofte University Hospital
Full Title: Long term effects of DPP-IV inhibitor treatment on the secretion and action of the incretin hormones in patients with type 2 diabetes
Medical condition: Type 2 diabetes diagnosed according to the criteria from WHO
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DK (Completed)
Trial results: (No results available)

EudraCT Number: 2006-001040-31 Sponsor Protocol Number: TUD-RELAZA-008 Start Date: 2006-11-23
Sponsor Name: University of Technology Dresden
Full Title: Treatment of the haematological relapse in patients suffering from acute myeloid leukaemia or myelodysplastic syndrome with 5-Azacytidin (Vidaza®) after hematopoietic stem cell transplantation "REL...
Medical condition: Patients suffering from acute myeloid leukaemia or myelodysplastic syndrome with falling CD34-chimerism or relapse after hematopoietic stem cell transplantation.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2006-004713-18 Sponsor Protocol Number: 01061 Start Date: 2006-11-23
Sponsor Name: European Lung Cancer Working Party
Full Title: A phase II study assessing the curative effect of the combination of lobectomy followed by mediastinal concomitant radiochemotherapy in patients with locally advanced unresectable stage III non-sma...
Medical condition: This phase II study aim to determine if radical radiochemotherapy on the mediastinum after lobectomy can be associated with significant long term survival in patients with initially unresectable st...
Disease: Version SOC Term Classification Code Term Level
8.1 10029105 Neoplasms malignant site unspecified NEC HLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: BE (Completed)
Trial results: (No results available)

EudraCT Number: 2006-001527-19 Sponsor Protocol Number: NAC-2006 Start Date: 2006-11-23
Sponsor Name: Hospital Universitario de Canarias
Full Title: ENSAYO CLÍNICO ALEATORIZADO FASE IV PARA EVALUAR LA EFICACIA COMPARATIVA DEL TRATAMIENTO CON AMOXICILINA-CLAVULÁNICO O LEVOFLOXACINO EN PACIENTES CON NEUMONÍA ADQUIRIDA EN LA COMUNIDAD (NAC)
Medical condition: Neumonía adquirida en la comunidad de gravedad leve-moderada (PSI I-III)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)
3
S'abonner